| 2025 | N-phenylmaleimide induces bioenergetic switch and suppresses tumor growth in glioblastoma tumorspheres by inhibiting SLC25A11
| CANCER CELL INTERNATIONAL |
| 2025 | A novel variant of telomerase reverse transcriptase (TERT) associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |
| 2025 | Differences in Treatment Outcomes Depending on the Adjuvant Treatment Modality in Craniopharyngioma
| YONSEI MEDICAL JOURNAL |
| 2025 | Interpretable multimodal transformer for prediction of molecular subtypes and grades in adult-type diffuse gliomas | NPJ DIGITAL MEDICINE(Nature partner journals digital medicine Digital medicine) |
| 2025 | Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection
| MOLECULAR CANCER |
| 2025 | Disruption of bioenergetics enhances the radio-sensitivity of patient-derived glioblastoma tumorspheres
| TRANSLATIONAL ONCOLOGY |
| 2024 | Incorporating supramaximal resection into survival stratification of IDH-wildtype glioblastoma: a refined multi-institutional recursive partitioning analysis | CLINICAL CANCER RESEARCH |
| 2024 | Deep learning-driven macroscopic AI segmentation model for brain tumor detection via digital pathology: Foundations for terahertz imaging-based AI diagnostics
| HELIYON |
| 2024 | Synergistic combination of perphenazine and temozolomide suppresses patient-derived glioblastoma tumorspheres | NEURO-ONCOLOGY |
| 2024 | Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery | NEURO-ONCOLOGY |
| 2024 | Identification of prognostic imaging biomarkers in H3 K27-altered diffuse midline gliomas in adults: impact of tumor oxygenation imaging biomarkers on survival | NEURORADIOLOGY |
| 2024 | Revisiting oligodendroglioma grading in the 2021 WHO classification: calcification and larger contrast-enhancing tumor volume may predict higher oligodendroglioma grade | NEURORADIOLOGY |
| 2024 | Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance | JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Revisiting gliomatosis cerebri in adult-type diffuse gliomas: a comprehensive imaging, genomic and clinical analysis
| ACTA NEUROPATHOLOGICA COMMUNICATIONS |
| 2024 | Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional study
| CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY |
| 2024 | Revisiting prognostic factors of gliomatosis cerebri in adult-type diffuse gliomas | JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas
| YONSEI MEDICAL JOURNAL |
| 2024 | Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment | NEURO-ONCOLOGY |
| 2024 | Comparison of Glioblastoma Cell Culture Platforms Based on Transcriptional Similarity with Paired Tissue
| PHARMACEUTICALS |
| 2024 | Clinical, qualitative imaging biomarkers, and tumor oxygenation imaging biomarkers for differentiation of midline-located IDH wild-type glioblastomas and H3 K27-altered diffuse midline gliomas in adults | EUROPEAN JOURNAL OF RADIOLOGY |
| 2024 | The importance of considering competing risks in recurrence analysis of intracranial meningioma
| JOURNAL OF NEURO-ONCOLOGY |
| 2024 | Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification | EUROPEAN RADIOLOGY |
| 2024 | 11C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET/CT in Glioma Classification and Survival Prediction | CLINICAL NUCLEAR MEDICINE |
| 2024 | High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma
| YONSEI MEDICAL JOURNAL |
| 2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 3-Summary of Imaging Findings on Glioneuronal and Neuronal Tumors | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2023 | Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme | JOURNAL OF NEURO-ONCOLOGY |
| 2023 | The Mediating Effect of Uncertainty in Illness on Cancer Coping in Patients With Primary Malignant Brain Tumors | CANCER NURSING |
| 2023 | Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium | NEURORADIOLOGY |
| 2023 | Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype | JOURNAL OF NEURO-ONCOLOGY |
| 2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 1-Key Points of the Fifth Edition and Summary of Imaging Findings on Adult-Type Diffuse Gliomas | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2023 | The 2021 WHO Classification for Gliomas and Implications on Imaging Diagnosis: Part 2-Summary of Imaging Findings on Pediatric-Type Diffuse High-Grade Gliomas, Pediatric-Type Diffuse Low-Grade Gliomas, and Circumscribed Astrocytic Gliomas | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2023 | Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study | NEUROSURGERY |
| 2023 | Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study | LANCET ONCOLOGY |
| 2023 | Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program | BRITISH JOURNAL OF CANCER |
| 2023 | C5 alpha secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2023 | Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging | JOURNAL OF NEUROSURGERY |
| 2023 | Astrocytic scar restricting glioblastoma via glutamate-MAO-B activity in glioblastoma-microglia assembloid
| Biomaterials Research |
| 2023 | What we need to know about uncertainty in illness among people with primary malignant brain tumours: A mixed-methods systematic review | JOURNAL OF CLINICAL NURSING |
| 2023 | Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
| DISCOVER ONCOLOGY |
| 2023 | Korean Brain Tumor Society Consensus Review for the Practical Recommendations on Glioma Management in Korea
| JOURNAL OF KOREAN NEUROSURGICAL SOCIETY |
| 2023 | Comparison of Single-Session, Neoadjuvant, and Adjuvant Embolization Gamma Knife Radiosurgery for Arteriovenous Malformation | NEUROSURGERY |
| 2023 | Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities
| JOURNAL OF NEURO-ONCOLOGY |
| 2023 | Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor | YONSEI MEDICAL JOURNAL |
| 2023 | Qualitative and Quantitative Magnetic Resonance Imaging Phenotypes May Predict CDKN2A/B Homozygous Deletion Status in Isocitrate Dehydrogenase-Mutant Astrocytomas: A Multicenter Study
| KOREAN JOURNAL OF RADIOLOGY |
| 2022 | Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
| 2022 | Federated learning enables big data for rare cancer boundary detection
| NATURE COMMUNICATIONS |
| 2022 | Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status | EUROPEAN RADIOLOGY |
| 2022 | Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma
| CANCERS |
| 2022 | Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |
| 2022 | Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma | MOLECULAR BIOLOGY REPORTS |
http://orcid.org/0000-0003-1509-9800
(7601549862)
